Product
Carboplatin/paclitaxel
1 clinical trial
1 indication
Indication
Ovarian CancerClinical trial
A Non-randomized Control Study Comparing Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian CancerStatus: Completed, Estimated PCD: 2019-11-30